Litigation Details for HELSINN HEALTHCARE S.A. v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2016)
✉ Email this page to a colleague
HELSINN HEALTHCARE S.A. v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-01-11 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-07-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 7,947,724; 7,947,725; 7,960,424; 8,598,219; 8,729,094 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. SAGENT PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for HELSINN HEALTHCARE S.A. v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-05-14 | 48 | Redacted Document | Such patents included those asserted in the instant cases, namely U.S. Patent Nos. 7,947,724; 7,947,…listed only the ‘724 and ‘725 patents. The remaining Asserted Patents were listed later, requiring the…Certification to each of those patents to secure final FDA approval before patent expiration. When Helsinn …continues to assert the remaining Asserted Patent, the ‘094 patent, against Teva. See Civ. A. No. 3:14-cv-…. Helsinn Sues Sagent, Among Others, For Patent Infringement on ALOXI® (palonosetron | External link to document |
| 2018-05-23 | 53 | Redacted Document | Such patents included those asserted in the instant cases, namely U.S. Patent Nos. 7,947,724; 7,947,…listed only the ‘724 and ‘725 patents. The remaining Asserted Patents were listed later, requiring the…Certification to each of those patents to secure final FDA approval before patent expiration. When Helsinn …continues to assert the remaining Asserted Patent, the ‘094 patent, against Teva. See Civ. A. No. 3:14-cv…. Helsinn Sues Sagent, Among Others, For Patent Infringement on ALOXI® (palonosetron | External link to document |
| 2018-06-27 | 71 | Redacted Document | Such patents included those asserted in the instant cases, namely U.S. Patent Nos. 7,947,724; 7,947,…listed only the ‘724 and ‘725 patents. The remaining Asserted Patents were listed later, requiring the…Certification to each of those patents to secure final FDA approval before patent expiration. When Helsinn …asserted claims of four of the Asserted Patents (all but the ‘094 patent), on which Helsinn filed a petition… only the ‘219 patent (and leaving undisturbed the holding as to other three patents).8 Helsinn Healthcare | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
